Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5251
Immersion
IMMR
$249M
| $436K | ﹤0.01% |
34,435
-7,224
| -17% | -$81.6K |
|
5252
CALL
Nektar Therapeutics
NKTR
$2.38B
| $435K | ﹤0.01% |
2,320
-4,793
| -67% | -$825K |
|
5253
Veracyte
VCYT
$3.54B
| $435K | ﹤0.01% |
39,028
+14,648
| +60% | +$144K |
|
|
BSFT
5254
DELISTED
BroadSoft, Inc.
BSFT
| $435K | ﹤0.01% |
12,574
-8,735
| -41% | -$310K |
|
|
PVA
5255
DELISTED
PENN VIRGINIA CORP
PVA
| $434K | ﹤0.01% |
98,930
-4,673
| -5% | -$26.5K |
|
|
GDJJ
5256
DELISTED
ProShares Ultra Junior Miners
GDJJ
| $433K | ﹤0.01% |
9,333
-37,834
| -80% | -$1.93M |
|
|
CRESY
5257
Cresud
CRESY
$809M
| $432K | ﹤0.01% |
37,229
+302
| +0.8% | +$3.62K |
|
5258
PUT
Teradyne
TER
$58.4B
| $432K | ﹤0.01% |
22,400
+1,300
| +6% | +$26K |
|
5259
PUT
Lands' End
LE
$371M
| $431K | ﹤0.01% |
17,360
+11,060
| +176% | +$318K |
|
5260
CALL
Progressive
PGR
$123B
| $431K | ﹤0.01% |
15,500
+200
| +1% | +$5.45K |
|
|
AMPE
5261
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $431K | ﹤0.01% |
606
+359
| +145% | +$383K |
|
|
MPG
5262
DELISTED
Metaldyne Performance Group Inc.
MPG
| $431K | ﹤0.01% |
23,750
-19,692
| -45% | -$373K |
|
5263
Stewart Information Services
STC
$2.06B
| $429K | ﹤0.01% |
10,778
-22,344
| -67% | -$855K |
|
5264
Xencor
XNCR
$1.53B
| $428K | ﹤0.01% |
19,488
-17,862
| -48% | -$304K |
|
|
NTRI
5265
CALL
DELISTED
NutriSystem, Inc.
NTRI
| $428K | ﹤0.01% |
17,200
+2,700
| +19% | +$60.6K |
|
|
XL
5266
CALL
DELISTED
XL Group Ltd.
XL
| $428K | ﹤0.01% |
11,500
+2,200
| +24% | +$82.5K |
|
5267
CALL
Lear
LEA
$6.74B
| $427K | ﹤0.01% |
3,800
-2,200
| -37% | -$253K |
|
|
FLXN
5268
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $427K | ﹤0.01% |
19,491
-1,019
| -5% | -$20.6K |
|
|
CLMS
5269
DELISTED
Calamos Asset Management, Inc.
CLMS
| $427K | ﹤0.01% |
34,866
-27,453
| -44% | -$339K |
|
5270
PUT
DNOW Inc
DNOW
$2.54B
| $426K | ﹤0.01% |
21,375
-25,675
| -55% | -$587K |
|
5271
Geospace Technologies
GEOS
$90.7M
| $426K | ﹤0.01% |
18,466
-3,105
| -14% | -$64.8K |
|
|
GRMN
5272
PUT
Garmin
GRMN
$56.8B
| $426K | ﹤0.01% |
9,700
-12,400
| -56% | -$571K |
|
5273
Unifirst Corp
UNF
$5.29B
| $426K | ﹤0.01% |
3,810
-4,528
| -54% | -$527K |
|
|
HNP
5274
DELISTED
Huaneng Power Intl, Inc.
HNP
| $426K | ﹤0.01% |
8,072
+2,578
| +47% | +$140K |
|
|
STAY
5275
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $426K | ﹤0.01% |
+22,677
| New | +$448K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.